Carbapenem versus Cefepime or Piperacillin-Tazobactam for Empiric Treatment of Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Escherichia coli in Patients with Hematologic Malignancy

Infections with extended-spectrum-β-lactamase (ESBL)-producing Escherichia coli are common in patients with hematologic malignancy. The utility of cefepime and piperacillin-tazobactam as empiric therapy for ESBL-producing E. coli bacteremia in patients with hematologic malignancy is largely unknown....

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Antimicrob Agents Chemother
Main Authors: Benanti, Grace E., Brown, Anne Rain T., Shigle, Terri Lynn, Tarrand, Jeffrey J., Bhatti, Micah M., McDaneld, Patrick M., Shelburne, Samuel A., Aitken, Samuel L.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2019
Teme:
Clinical Therapeutics
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6355563/
https://ncbi.nlm.nih.gov/pubmed/30509935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01813-18
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki